全文获取类型
收费全文 | 12493篇 |
免费 | 510篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 368篇 |
儿科学 | 331篇 |
妇产科学 | 352篇 |
基础医学 | 2110篇 |
口腔科学 | 223篇 |
临床医学 | 914篇 |
内科学 | 1967篇 |
皮肤病学 | 312篇 |
神经病学 | 1124篇 |
特种医学 | 955篇 |
外科学 | 2066篇 |
综合类 | 65篇 |
一般理论 | 1篇 |
预防医学 | 598篇 |
眼科学 | 347篇 |
药学 | 718篇 |
中国医学 | 13篇 |
肿瘤学 | 565篇 |
出版年
2021年 | 144篇 |
2020年 | 122篇 |
2019年 | 134篇 |
2018年 | 200篇 |
2017年 | 180篇 |
2016年 | 273篇 |
2015年 | 275篇 |
2014年 | 313篇 |
2013年 | 465篇 |
2012年 | 467篇 |
2011年 | 422篇 |
2010年 | 386篇 |
2009年 | 327篇 |
2008年 | 442篇 |
2007年 | 438篇 |
2006年 | 480篇 |
2005年 | 465篇 |
2004年 | 423篇 |
2003年 | 386篇 |
2002年 | 411篇 |
2001年 | 254篇 |
2000年 | 264篇 |
1999年 | 265篇 |
1998年 | 216篇 |
1997年 | 158篇 |
1996年 | 124篇 |
1995年 | 109篇 |
1994年 | 98篇 |
1993年 | 93篇 |
1992年 | 137篇 |
1991年 | 141篇 |
1990年 | 118篇 |
1989年 | 111篇 |
1988年 | 97篇 |
1987年 | 97篇 |
1986年 | 97篇 |
1985年 | 87篇 |
1984年 | 84篇 |
1983年 | 86篇 |
1982年 | 84篇 |
1981年 | 85篇 |
1978年 | 83篇 |
1974年 | 83篇 |
1973年 | 97篇 |
1933年 | 96篇 |
1932年 | 93篇 |
1931年 | 86篇 |
1930年 | 102篇 |
1928年 | 82篇 |
1925年 | 84篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
993.
Otto Kalliokoski Jann Hau Camilla Schumacher-Petersen 《General and comparative endocrinology》2010,168(3):450-445
Quantification of corticosterone metabolites excreted in faeces and urine is increasingly being used for assessment of preceding corticosterone concentrations in the circulation. This is a promising approach to non-invasive stress assessment in laboratory rodents. It is however unknown whether the proportions of corticosterone metabolites excreted in faeces and urine may differ, depending on the concentration of corticosterone in blood. This uncertainty undermines the applicability of urinary and faecal corticosterone metabolite measurements as biomarkers for stress. Therefore, the terminal distribution and time course of corticosterone excretion, after intravenous injection of varying corticosterone concentrations, was investigated in female mice. Female BALB/c mice excreted 60% of all corticosterone in the urine with an approximate delay of 5 h from tail vein administration. The remaining 40% were excreted in faeces, with an approximate delay of 9 h from administration. The faecal/urinary excretion ratio, as well as time course of excretion, remained unaltered by administration of various doses of corticosterone covering the entire physiological range of serum corticosterone. Although currently untested for other strains of mice and species of animals, these findings add credence to the utility of faecal and urinary corticosterone as non-invasive biomarkers for physiological stress. 相似文献
994.
Geyer BC Kannan L Garnaud PE Broomfield CA Cadieux CL Cherni I Hodgins SM Kasten SA Kelley K Kilbourne J Oliver ZP Otto TC Puffenberger I Reeves TE Robbins N Woods RR Soreq H Lenz DE Cerasoli DM Mor TS 《Proceedings of the National Academy of Sciences of the United States of America》2010,107(47):20251-20256
The concept of using cholinesterase bioscavengers for prophylaxis against organophosphorous nerve agents and pesticides has progressed from the bench to clinical trial. However, the supply of the native human proteins is either limited (e.g., plasma-derived butyrylcholinesterase and erythrocytic acetylcholinesterase) or nonexisting (synaptic acetylcholinesterase). Here we identify a unique form of recombinant human butyrylcholinesterase that mimics the native enzyme assembly into tetramers; this form provides extended effective pharmacokinetics that is significantly enhanced by polyethylene glycol conjugation. We further demonstrate that this enzyme (but not a G117H/E197Q organophosphorus acid anhydride hydrolase catalytic variant) can prevent morbidity and mortality associated with organophosphorous nerve agent and pesticide exposure of animal subjects of two model species. 相似文献
995.
Maritza Zavaleta-Pastor Christian Sohlenkamp Jun-Lian Gao Ziqiang Guan Rahat Zaheer Turlough M. Finan Christian R. H. Raetz Isabel M. López-Lara Otto Geiger 《Proceedings of the National Academy of Sciences of the United States of America》2010,107(1):302-307
Rhizobia are Gram-negative soil bacteria able to establish nitrogen-fixing root nodules with their respective legume host plants. Besides phosphatidylglycerol, cardiolipin, and phosphatidylethanolamine, rhizobial membranes contain phosphatidylcholine (PC) as a major membrane lipid. Under phosphate-limiting conditions of growth, some bacteria replace their membrane phospholipids with lipids lacking phosphorus. In Sinorhizobium meliloti, these phosphorus-free lipids are sulfoquinovosyl diacylglycerol, ornithine-containing lipid, and diacylglyceryl trimethylhomoserine (DGTS). Pulse–chase experiments suggest that the zwitterionic phospholipids phosphatidylethanolamine and PC act as biosynthetic precursors of DGTS under phosphorus-limiting conditions. A S. meliloti mutant, deficient in the predicted phosphatase was unable to degrade PC or to form DGTS in a similar way as the wild type. Cell-free extracts of Escherichia coli, in which SMc00171 had been expressed, convert PC to phosphocholine and diacylglycerol, showing that SMc00171 functions as a phospholipase C. Diacylglycerol , in turn, is the lipid anchor from which biosynthesis is initiated during the formation of the phosphorus-free membrane lipid DGTS. Inorganic phosphate can be liberated from phosphocholine. These data suggest that, in S. meliloti under phosphate-limiting conditions, membrane phospholipids provide a pool for metabolizable inorganic phosphate, which can be used for the synthesis of other essential phosphorus-containing biomolecules. This is an example of an intracellular phospholipase C in a bacterial system; however, the ability to degrade endogenous preexisting membrane phospholipids as a source of phosphorus may be a general property of Gram-negative soil bacteria. SMc00171相似文献
996.
Väänänen RM Rissanen M Kauko O Junnila S Väisänen V Nurmi J Alanen K Nurmi M Pettersson K 《Clinical biochemistry》2008,41(1-2):103-108
Objectives:To develop a quantitative, internally standardized real-time RT-PCR assay for prostate cancer antigen 3 (PCA3), a non-translated gene found to be prostate-specific and highly overexpressed in cancer, and examine the role of PCA3 in peripheral blood with a small sample cohort.Design and methods:The RT-PCR assay for PCA3 is based on target-specific lanthanide probes. Peripheral blood from 91 prostatic cancer/disorder patients and healthy controls was assayed for PCA3 and prostate-specific antigen (PSA) expression.Results:The dynamic range of the assay reaches over eight orders of magnitude and the limit of quantification is 800 copies per milliliter blood. Peripheral blood from 2/9 patients with metastasized cancers were PCA3 positive, whereas all the other samples were negative. Eight samples were PSA positive.Conclusions:The degree of PCA3 positivity in circulating cells from prostate cancer patients is low compared to that of PSA. In contrast to some previous reports, we found no PCA3 expression in healthy individuals. 相似文献
997.
Søren Langkilde Tafadzwa Mandimika Malene Schrøder Otto Meyer Wout Slob Ad Peijnenburg Morten Poulsen 《Food and chemical toxicology》2009
Glycoalkaloids α-solanine and α-chaconine are naturally present toxicants in the potato plant (Solanumtuberosum). Human intake of high doses of glycoalkaloids has led to acute intoxication, in severe cases coma and death. Previous studies have indicated that the ratio of α-solanine to α-chaconine may determine the degree and nature of the glycoalkaloid toxicity in potatoes, as the toxicity of the two alkaloids act synergistically. The aim of the present study was to investigate whether an altered ratio of α-solanine and α-chaconine would reduce the toxicity of the glycoalkaloids. The Syrian Golden hamster was given daily doses of α-solanine and α-chaconine by gavage for 28 days. Doses of up to 33.3 mg total glycoalkaloids/kg body weight were applied in ratios of 1:3.7 and 1:70 (α-solanine:α-chaconine). Administration of the highest doses of both ratios resulted in distended and fluid filled small intestines and stomach. Animals receiving the ratio with the reduced content of α-solanine were less affected compared to those receiving the other ratio. Gene expression profiling experiments were conducted using RNA from epithelial scrapings from the small intestines of the hamsters administered the highest doses of the glycoalkaloid treatments. In general, more differential gene expression was observed in the epithelial scrapings of the hamsters fed the ratio of 1:3.7. Mostly, pathways involved in lipid and energy metabolism were affected by the ratio of 1:3.7. 相似文献
998.
999.
Teplan V Schück O Racek J Mareckova O Stollova M Hanzal V Malý J 《Wiener klinische Wochenschrift》2008,120(15-16):478-485
BACKGROUND: Levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) are elevated in chronic kidney disease (CKD) and may contribute to vascular complications. In this study we tested the hypothesis that elevated ADMA can be reduced in obese CKD patients by long-term administration of a low-protein diet supplemented with keto-amino acids. PATIENTS AND METHODS: In a long-term prospective double-blind placebo-controlled randomized trial, we evaluated for a period of 36 months a total of 111 CKD patients (54 men, 57 women) aged 22-76 years with obesity (BMI >or= 30 kg/m(2)) and an inulin clearance rate (C(in)) of 22-40 ml/min/1.73 m(2). All patients were on a low-protein diet containing 0.6 g protein/kg BW per day and 120-125 kJ/kg BW per day. The diet was randomly supplemented with keto-amino acids at a dosage of 100 mg/kg BW per day (66 patients, Group I); 65 patients received placebo (Group II). RESULTS: During the study period, the glomerular filtration rate decreased slightly in Group I (C(in) from 32.4 +/- 12.6 to 29.8 +/- 8.6 ml/min/1.73 m(2)) and more markedly in Group II (from 33.2 +/- 12.6 to 23.2 +/- 98.4 ml/min/1.73 m(2), P < 0.01). BMI decreased significantly in Group I (from 32.0 +/- 3.3 to 26.1 +/- 4.0 kg/m(2), P < 0.01) and was linked to reduced volume of visceral fat measured by MRI (P < 0.01). Reduction of BMI in Group II was not significant. In Group I, there was a significant decrease in the plasma level of ADMA (from 2.5 +/- 0.5 to 1.3 +/- 0.4 micromol/l, P < 0.01), but ADMA remained unchanged in Group II. A further remarkable finding in Group I was reduction in the plasma concentration of pentosidine (from 480 +/- 170 to 320 +/- 120 microg/l, P < 0.01) and decrease of proteinuria (from 3.8 +/- 2.24 to 1.6 +/- 1.0 g/24 h, P < 0.02). Plasma adiponectin rose in Group I (P < 0.01). Analysis of the lipid spectrum revealed a mild but significant decrease in total cholesterol and LPD-cholesterol (P < 0.02), more pronounced in Group I. There was also a decrease in plasma triglycerides in Group I (from 3.9 +/- 1.6 down to 2.2 +/- 0.6 mmol/l, P < 0.01) and a decrease in glycated hemoglobin (from 7.2 +/- 1.4% to 4.2 +/- 0.8%, P < 0.02). CONCLUSION: Compared with the placebo group, long term co-administration of a low-protein diet and keto-amino acids in CKD patients with obesity led to decreases of ADMA, visceral body fat and proteinuria. Concomitant decreases of glycated hemoglobin, LDL-cholesterol and pentosidine may also contribute to the delay in progression of renal failure. 相似文献
1000.